Pharma Research (214450)
파마리서치 KOSDAQ GLOBAL 의료용품 및 기타 의약 관련제품 제조업
Close (Aug 19, 2026)
₩391,000
-0.51%
Market cap
₩4T ($2.9B)
52-week range
₩255,000 –
₩713,000
P/E · P/B · Div yield
24.60 · 6.56 ·
0.95%
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-08-19 | ₩391,000 | +₩10.0bn | ₩-1.3bn | ₩-8.7bn |
| 2026-08-18 | ₩393,000 | +₩34.8bn | ₩-15.6bn | ₩-18.5bn |
| 2026-08-14 | ₩398,000 | +₩0.4bn | ₩-26.9bn | +₩25.7bn |
| 2026-08-13 | ₩425,500 | +₩36.1bn | ₩-12.4bn | ₩-21.6bn |
| 2026-08-12 | ₩408,000 | +₩11.1bn | ₩-8.6bn | ₩-0.5bn |
| 2026-08-11 | ₩417,000 | ₩-4.7bn | +₩7.3bn | ₩-2.5bn |
| 2026-08-10 | ₩410,000 | +₩31.3bn | +₩16.0bn | ₩-45.0bn |
| 2026-08-07 | ₩378,500 | ₩-22.2bn | +₩1.0bn | +₩20.9bn |
| 2026-08-06 | ₩394,500 | ₩-4.6bn | +₩11.5bn | ₩-8.9bn |
| 2026-08-05 | ₩378,000 | +₩37.1bn | ₩-14.2bn | ₩-21.7bn |
| 2026-08-04 | ₩384,500 | ₩-1.1bn | ₩-0.9bn | +₩2.1bn |
| 2026-08-03 | ₩372,000 | +₩8.4bn | +₩17.0bn | ₩-26.0bn |
| 2026-07-31 | ₩338,500 | +₩16.3bn | ₩-27.2bn | +₩11.2bn |
| 2026-07-30 | ₩348,000 | +₩0.8bn | +₩2.6bn | ₩-2.9bn |
| 2026-07-29 | ₩391,000 | ₩-32.3bn | +₩84.4bn | ₩-50.8bn |
| 2026-07-28 | ₩375,500 | ₩-56.3bn | +₩90.5bn | ₩-37.4bn |
| 2026-07-27 | ₩370,000 | ₩-11.3bn | +₩24.2bn | ₩-11.8bn |
| 2026-07-24 | ₩357,000 | ₩-2.9bn | +₩8.1bn | ₩-5.8bn |
| 2026-07-23 | ₩360,000 | +₩15.4bn | +₩16.7bn | ₩-32.0bn |
| 2026-07-22 | ₩322,500 | ₩-2.3bn | ₩-7.8bn | +₩10.1bn |
| 2026-07-21 | ₩341,500 | ₩-0.2bn | +₩9.1bn | ₩-8.9bn |
| 2026-07-20 | ₩327,000 | +₩5.1bn | +₩0.7bn | ₩-4.7bn |
| 2026-07-16 | ₩336,500 | ₩-1.9bn | +₩7.3bn | ₩-7.7bn |
| 2026-07-15 | ₩327,500 | ₩-5.5bn | ₩-2.4bn | +₩8.0bn |
| 2026-07-14 | ₩318,500 | ₩-5.1bn | ₩-3.3bn | +₩7.9bn |
| 2026-07-13 | ₩330,500 | ₩-3.7bn | +₩11.5bn | ₩-7.1bn |
| 2026-07-10 | ₩319,500 | +₩2.4bn | +₩3.8bn | ₩-7.4bn |
| 2026-07-09 | ₩309,000 | ₩-0.8bn | +₩0.3bn | +₩0.9bn |
| 2026-07-08 | ₩327,000 | ₩-18.6bn | +₩12.8bn | +₩5.9bn |
| 2026-07-07 | ₩340,500 | ₩-2.8bn | +₩32.3bn | ₩-28.8bn |
| 2026-07-06 | ₩314,000 | +₩1.4bn | ₩-9.8bn | +₩9.1bn |
| 2026-07-03 | ₩341,000 | +₩7.1bn | ₩-1.3bn | ₩-4.8bn |
| 2026-07-02 | ₩360,500 | ₩-17.3bn | +₩25.8bn | ₩-8.0bn |
| 2026-07-01 | ₩366,500 | ₩-19.0bn | +₩25.4bn | ₩-8.0bn |
| 2026-06-30 | ₩363,000 | ₩-21.3bn | +₩34.0bn | ₩-13.3bn |
| 2026-06-29 | ₩349,000 | +₩9.4bn | +₩23.1bn | ₩-33.8bn |
| 2026-06-26 | ₩324,000 | ₩-19.4bn | +₩25.6bn | ₩-7.7bn |
| 2026-06-25 | ₩322,500 | +₩12.9bn | ₩-4.2bn | ₩-9.3bn |
| 2026-06-24 | ₩304,500 | +₩6.8bn | +₩5.8bn | ₩-12.6bn |
| 2026-06-23 | ₩280,000 | +₩1.1bn | +₩4.0bn | ₩-5.4bn |
| 2026-06-22 | ₩293,500 | ₩-2.8bn | +₩1.7bn | ₩-0.1bn |
| 2026-06-19 | ₩294,000 | +₩6.8bn | ₩-0.9bn | ₩-5.9bn |
| 2026-06-18 | ₩298,000 | ₩-0.1bn | +₩1.6bn | ₩-1.2bn |
| 2026-06-17 | ₩302,000 | +₩2.6bn | +₩2.0bn | ₩-4.3bn |
| 2026-06-16 | ₩295,000 | ₩-1.4bn | ₩-1.9bn | +₩3.7bn |
| 2026-06-15 | ₩303,500 | +₩4.1bn | +₩3.1bn | ₩-8.1bn |
| 2026-06-12 | ₩289,000 | +₩3.6bn | ₩-2.6bn | ₩-1.9bn |
| 2026-06-11 | ₩288,500 | +₩9.7bn | ₩-7.3bn | ₩-1.3bn |
| 2026-06-10 | ₩281,500 | +₩4.4bn | +₩0.2bn | ₩-3.9bn |
| 2026-06-09 | ₩276,000 | +₩10.3bn | ₩-1.9bn | ₩-8.3bn |
| 2026-06-08 | ₩259,000 | +₩7.6bn | ₩-7.7bn | +₩0.8bn |
| 2026-06-05 | ₩286,500 | ₩-0.2bn | +₩0.6bn | ₩-0.3bn |
| 2026-06-04 | ₩296,500 | +₩4.5bn | +₩2.5bn | ₩-7.1bn |
| 2026-06-02 | ₩290,500 | ₩-0.1bn | +₩3.5bn | ₩-3.4bn |
| 2026-06-01 | ₩298,000 | +₩0.8bn | +₩2.9bn | ₩-2.7bn |
| 2026-05-29 | ₩295,000 | +₩1.4bn | +₩1.8bn | ₩-3.9bn |
| 2026-05-28 | ₩297,000 | ₩-1.4bn | ₩-1.7bn | +₩2.7bn |
| 2026-05-27 | ₩299,000 | ₩-0.6bn | ₩-2.0bn | +₩3.8bn |
| 2026-05-26 | ₩312,000 | ₩-2.1bn | +₩0.1bn | +₩2.1bn |
| 2026-05-22 | ₩305,000 | +₩3.4bn | +₩3.0bn | ₩-7.2bn |
| 2026-05-21 | ₩293,500 | ₩-2.3bn | ₩-4.1bn | +₩6.2bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | +₩10.0bn | +$7M | ₩-1.3bn | ₩-8.7bn |
| 5 days | +₩92.4bn | +$66M | ₩-64.7bn | ₩-23.6bn |
| 20 days | +₩64.0bn | +$45M | +₩164.5bn | ₩-224.1bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩261bn ($185M) | – | ₩92bn ($65M) | ₩77bn ($55M) |
| 2024 | ₩350bn ($248M) | +34.10% | ₩126bn ($89M) | ₩89bn ($63M) |
| 2025 | ₩536bn ($380M) | +53.20% | ₩214bn ($152M) | ₩168bn ($119M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1410.07/$) for reference only.